C
Novo Nordisk A/S NONOF
$65.14 $1.141.78% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 11.02B 12.25B 10.51B 9.82B 9.52B
Total Other Revenue -- -- -- -- --
Total Revenue 11.02B 12.25B 10.51B 9.82B 9.52B
Cost of Revenue 1.82B 1.72B 1.67B 1.48B 1.44B
Gross Profit 9.20B 10.52B 8.84B 8.34B 8.07B
SG&A Expenses 2.27B 2.90B 2.44B 2.32B 2.10B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -1.97M -105.76M 14.88M -58.44M 82.70M
Total Operating Expenses 5.54B 6.16B 5.52B 5.26B 4.88B
Operating Income 5.47B 6.08B 4.98B 4.56B 4.64B
Income Before Tax 5.22B 5.08B 5.07B 3.66B 4.65B
Income Tax Expenses 1.13B 1.05B 1.04B 762.14M 948.04M
Earnings from Continuing Operations 4.10B 4.03B 4.02B 2.89B 3.70B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 4.10B 4.03B 4.02B 2.89B 3.70B
EBIT 5.47B 6.08B 4.98B 4.56B 4.64B
EBITDA 6.01B 6.33B 5.30B 5.02B 4.95B
EPS Basic 0.92 0.91 0.90 0.65 0.83
Normalized Basic EPS 0.74 0.83 0.71 0.63 0.65
EPS Diluted 0.92 0.91 0.90 0.65 0.83
Normalized Diluted EPS 0.73 0.83 0.71 0.63 0.65
Average Basic Shares Outstanding 4.44B 4.45B 4.45B 4.46B 4.46B
Average Diluted Shares Outstanding 4.45B 4.46B 4.46B 4.47B 4.47B
Dividend Per Share -- 1.13 0.00 0.51 --
Payout Ratio 121.49% 0.00% 57.08% 0.00% 112.40%